TY - JOUR
T1 - Salmonella septic arthritis in a patient receiving etanercept
T2 - Case report and review of the literature
AU - Sky, Karen
AU - Arroyo, Col Ramon A.
AU - Collamer, Maj Angelique N.
PY - 2013/12
Y1 - 2013/12
N2 - Antitumor necrosis factor alpha agents are known to increase the risk for severe and atypical infections. Numerous atypical organisms have been reported previously, however, there is a paucity of reports of Salmonella as a complication of these therapies. We report a case of a 69-year-old female who developed Salmonella septic arthritis of the pubic symphysis while taking etanercept that resolved with cessation of etanercept and antibiotic treatment and we review the literature regarding this complication. Awareness of susceptibility to Gram-negative intracellular organisms and reactivation of dormant infections due to the mechanism of action of antitumor necrosis factor alpha medications is vital.
AB - Antitumor necrosis factor alpha agents are known to increase the risk for severe and atypical infections. Numerous atypical organisms have been reported previously, however, there is a paucity of reports of Salmonella as a complication of these therapies. We report a case of a 69-year-old female who developed Salmonella septic arthritis of the pubic symphysis while taking etanercept that resolved with cessation of etanercept and antibiotic treatment and we review the literature regarding this complication. Awareness of susceptibility to Gram-negative intracellular organisms and reactivation of dormant infections due to the mechanism of action of antitumor necrosis factor alpha medications is vital.
UR - http://www.scopus.com/inward/record.url?scp=84889679354&partnerID=8YFLogxK
U2 - 10.7205/MILMED-D-13-00284
DO - 10.7205/MILMED-D-13-00284
M3 - Article
C2 - 24306025
AN - SCOPUS:84889679354
SN - 0026-4075
VL - 178
SP - 1384
EP - 1387
JO - Military Medicine
JF - Military Medicine
IS - 12
ER -